Home › Research › Brain scans and imaging
The short-chain fatty acid butyrate prevents gut-brain amyloid-β pathology and neuroinflammation in an Alzheimer mouse model
Rodrigue Brossaud, Thibauld Oullier, Anne Claire Hardy Bessard, P. Aubert, Lisa Brossard, Maxime M. Mahé, Martial Caillaud, Giada Delfino et al.. Molecular Psychiatry, 2026-03-05
Topic: Brain proteins, microglia and lab models
Plain-language summary
Collectively, these findings suggest that Aβ promotes gut symptoms through alteration of ENS connectivity and butyrate counteracts these impairments with an amelioration of neuroinflammation and memory function in AD model.
What this study adds
Evidence grade: Low
In a mouse model of Alzheimer's disease, the short-chain fatty acid butyrate reduced neuroinflammation and improved memory function. These findings are from an animal model and do not yet show whether butyrate would have the same effects in people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Brossaud, R., Oullier, T., Bessard, A. C. H., Aubert, P., Brossard, L., Mahé, M. M., et al. (2026). The short-chain fatty acid butyrate prevents gut-brain amyloid-β pathology and neuroinflammation in an Alzheimer mouse model. Molecular Psychiatry. https://doi.org/10.1038/s41380-026-03522-6
Vancouver
Brossaud R, Oullier T, Bessard ACH, Aubert P, Brossard L, Mahé MM, et al. The short-chain fatty acid butyrate prevents gut-brain amyloid-β pathology and neuroinflammation in an Alzheimer mouse model. Molecular Psychiatry. 2026. doi:10.1038/s41380-026-03522-6. PMID: 41786890.
BibTeX
@article{brossaud2026-41786890,
author = {Brossaud, Rodrigue and Oullier, Thibauld and Bessard, Anne Claire Hardy and Aubert, P. and Brossard, Lisa and Mahé, Maxime M. and Caillaud, Martial and Delfino, Giada and others},
title = {{The short-chain fatty acid butyrate prevents gut-brain amyloid-β pathology and neuroinflammation in an Alzheimer mouse model}},
journal = {Molecular Psychiatry},
year = {2026},
doi = {10.1038/s41380-026-03522-6},
pmid = {41786890},
url = {https://doi.org/10.1038/s41380-026-03522-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Collectively, these findings suggest that Aβ promotes gut symptoms through alteration of ENS connectivity and butyrate counteracts these impairments with an amelioration of neuroinflammation and memory function in AD model.
Why it matters
In a mouse model of Alzheimer's disease, the short-chain fatty acid butyrate reduced neuroinflammation and improved memory function. These findings are from an animal model and do not yet show whether butyrate would have the same effects in people.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Evidence strengthLow
How this study scored 49/100
Published in a leading specialty journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Molecular Psychiatry) |
| Journal's citation record | 3 / 4 | Molecular Psychiatry: journal h-index 318 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “mouse”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 13 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 6 / 6 | Cited 54.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Moustapha Cissé: h-index 16 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Inserm: institution h-index 1,988 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41786890) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s41380-026-03522-6
- PubMed: 41786890
- Original source →
- Free full text: Molecular Psychiatry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Brain scans and imaging from nearby years
Also tagged “tdp-43”
1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.